Short Acting Opioids or Rapid Onset Opioids for the management of breakthrough cancer pain
Published 27th April 2023
Prof. Andrew Davies discusses the differences between Short-Acting Opioids (SAO’s) and Rapid Onset Opioids (ROO’s) for the management of breakthrough cancer pain.
Sign up to MediScene
To access this content, please register or log in.